Ionis therapeutics stock
Web13 apr. 2024 · The company’s stock has been forecasted to trade at an average price of $8.32 over the course of the next 52 weeks, with a low of $4.00 and a high of $16.00. Based on these price targets, the low is 28.7% off current price, whereas the price has to move -185.2% to reach the yearly target high. Web6 apr. 2024 · The average twelve-month price prediction for Ionis Pharmaceuticals is $45.17 with a high price target of $67.00 and a low price target of $27.00. Learn more on IONS's …
Ionis therapeutics stock
Did you know?
WebIonis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in …
WebIonis Pharmaceuticals, Inc. (IONS) Stock Price, News, Quote & History - Yahoo Finance Personal Finance U.S. markets closed S&P Futures 0.00(0.00%) Dow Futures 33,683.00 … WebIonis Pharmaceuticals Inc Follow Share $37.23 After Hours: $37.23 (0.00%) 0.00 Closed: Apr 11, 7:29:48 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Crispr …
Web16 dec. 2024 · Ionis ( NASDAQ: IONS) is currently trading at $29.73 while it has an intrinsic value of $49.27. The short-term catalyst that will move this stock in 2024 is increased market share for Spinraza.... Web10 apr. 2024 · Bitritto-Garg covers the Healthcare sector, focusing on stocks such as Amylyx Pharmaceuticals Inc, ACADIA Pharmaceuticals, and Ionis Pharmaceuticals. Sarepta Therapeutics has an analyst consensus ...
Web13 apr. 2024 · Get undefined (IONS.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments
Web1 sep. 2024 · Ionis Pharmaceuticals has agreed to purchase the remaining outstanding shares in Akcea Therapeutics for a total cash consideration of about $500m, or $18.15 per share. Ionis expects to benefit via financial upside from Akcea’s pipeline and commercial medicines. Credit: Ionis Pharmaceuticals. dating supervisors in the workplaceWebView today's Ionis Pharmaceuticals Inc stock price and latest IONS news and analysis. Create real-time notifications to follow any changes in the live stock price. bj\u0027s turkey deal 2021Web12 apr. 2024 · Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular … dating summary examplesWebLegal Name Ionis Pharmaceuticals, Inc. Stock Symbol NASDAQ:IONS Company Type For Profit Phone Number (760)931-9200 Ionis Pharmaceuticals is a pharmaceutical company. It specializes in RNA-targeted drug discovery and development. bj\u0027s tv wall mountsWeb28 mrt. 2024 · For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. bj\\u0027s twin mattressesWeb28 feb. 2024 · Ionis reports fourth quarter and full year 2024 financial results. Feb 21, 2024. Ionis announces new donidalorsen data and presentations at the 2024 American … bj\u0027s twin mattressWeb13 apr. 2024 · United Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $282.88, representing a 24.6% upside. In a report issued on April 10, UBS also maintained a Buy... bj\\u0027s twin bed mattress \\u0026 box spring sale